Clinical Trial Detail

NCT ID NCT02595918
Title Nivolumab in Treating Patients With HIgh-Risk Non-Metastatic Kidney Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

clear cell renal cell carcinoma

Therapies

Nivolumab

Age Groups: adult

No variant requirements are available.